Document is current
Any future updates will be listed below
-
Authors
Wang, Yanhong
Li, Jiaxuan
Tian, Jianhui
Liu, Ze
Yao, Wang
Liu, Jiajun
Que, Zujun
Shangguan, Wenji
-
Funding
Funding for this research was provided by:
Shanghai Frontier Research Base of Disease and Syndrome Biology of Inflammatory Cancer Transformation (2021KJ03-12)
National TCM Advantageous Specialty Construction Project of the National Administration of Traditional Chinese Medicine (Oncology Department-2024-510)
Clinical Evaluation of the Tiaoshen Anti-Cancer Regimen in Treating Psycho-Neurological Symptom Cluster in Ovarian Cancer [the National Health Commission of the People’s Republic of China (No. 2024ZD0521402)
the Key Specialty Development Project of Baoshan Branch, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (rbzdzk-2023-002)
- License Information
-
More Information
Article History
Received: 17 September 2025
Accepted: 15 December 2025
First Online: 30 December 2025
Declarations
:
: This study primarily used publicly available, de-identified datasets (TCGA, GTEx, etc.), and therefore no additional ethics approval or patient consent was required. The lung nodule and lung cancer specimens used in this work were provided by Shanghai Pulmonary Hospital and collected in accordance with institutional ethical guidelines.
: Not applicable. This manuscript does not contain individual person’s data in any form.
: The authors declare no competing interests.
